McKesson Corporation (MCK) Stock Price Today
Aura AI Summary
Key Stats
- $103.45BMarket Cap
- 902,251Volume
- HealthSector
- $995.6952W High
- $690.1352W Low
- 73 DaysTypical Hold Time
- $109.99BEnterprise Value
- 0.42%Div Yield
- 36% Sell | 64% BuyTrading Activity
Track McKesson Corporation (MCK) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, McKesson Corporation has traded between a low of $690.13 and a high of $995.69, highlighting its annual price range. Buy and sell McKesson Corporation shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Most Recent News
ON Semiconductor drives AI and EV growth with new power tech and a 2030 vision despite neutral rating.
ON Semiconductor is focusing on advanced power-density technologies for AI data centers and electric vehicles, aiming for $2.5 billion revenue from AI alone by 2030. Despite a Neutral rating from UBS, the company introduced its Embedded Power Platfor...

Salesforce targets $63B revenue by 2030, boosted by new AIforce platform and strong analyst support.
Salesforce, a leader in cloud-based CRM software, is driving future growth with its new AIforce platform and ambitious financial goals. The company aims to exceed $63 billion in revenue by 2030, reflecting strong demand for its AI and core software p...

Oscar Health stock jumps 126% on strong ACA enrollment growth and improved financial outlook
Oscar Health's stock has surged 126% this year, driven by a 47% increase in ACA marketplace enrollment despite overall market declines. The company, now the second-largest insurer on the ACA exchange, has raised its earnings outlook and improved its ...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.